- ICH GCP
- US Clinical Trials Registry
- Forskere
- Tyskland
- Glioblastom
Medisinske spesialister fra Tyskland merket som etterforskere i kliniske studier som studerer Glioblastom
Totalt 43 resultater
-
Anca-Ligia Grosu, ProfSett i:
- Baden-Wuerttemberg, Freiburg i. Br., Department of Radiotherapy, University Hospital Freiburg
- Freiburg, University Medical Center Freiburg
Prøver:- NCT04471844 (Hovedetterforsker)
- NCT01252459 (Hovedetterforsker)
-
Antje Wick, MDSett i:
- Baden-Württemberg, Heidelberg, Universitätsklinikum Heidelberg
- Heidelberg, Universitaetsklinikum Heidelberg
- Heidelberg, Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital
- Heidelberg, Universitätsklinik Heidelberg
Prøver:- NCT03970447 (Hovedetterforsker)
- NCT04901806 (Hovedetterforsker)
- NCT04402073 (Hovedetterforsker)
- NCT05580562 (Hovedetterforsker)
-
Axel Madlung, MDSett i:
- Berlin, Charité - Universitätsmedizin
Prøver:- NCT02685605 (Underetterforsker)
Betingelser: -
Clemens Seidel, DrSett i:
- Leipzig, University Hospital Leipzig
Prøver:- NCT04471844 (Hovedetterforsker)
Betingelser: -
Daniela Schulz-Ertner, MDSett i:
- Baden-Württemberg, Heidelberg, University of Heidelberg
Prøver:- NCT00311857 (Hovedetterforsker)
Betingelser: -
David Kaul, PD Dr.Sett i:
- Berlin, Charité Universitätsmedizin Berlin
Prøver:- NCT06140875 (Hovedetterforsker)
Betingelser: -
Dorothea Miller, MDSett i:
- Northrhine Westphalia, Bochum, Klinik für Neurologie, Knappschaftskrankenhaus Bochum
Prøver:- NCT03395587 (Hovedetterforsker)
Betingelser: -
Ghazaleh Tabatabai, MDSett i:
- Tuebingen, Universitaetsklinikum Tuebingen- Crona Kliniken
- Tübingen, Universitätsklinikum Tübingen
Prøver:- NCT03970447 (Hovedetterforsker)
- NCT04402073 (Hovedetterforsker)
- NCT05904119 (Hovedetterforsker)
Betingelser: -
Hans Theodor Eich, Prof. Dr.Sett i:
- Münster, University Hospital Münster, Klinik für Neurochirurgie
Prøver:- NCT05590689 (Underetterforsker)
Betingelser: -
Julia Onken, MDSett i:
- Berlin, Charité - Universitätsmedizin
Prøver:- NCT02685605 (Underetterforsker)
Betingelser: -
Klaus H Kahl, MDSett i:
- Augsburg, University Hospital Augsburg
Prøver:- NCT02685605 (Hovedetterforsker)
Betingelser: -
Knut Send, MDSett i:
- Krefeld, Helios Klinikum Krefeld, Klinik für Neurochirurgie
Prøver:- NCT03395587 (Underetterforsker)
Betingelser: -
Marc Münter, MDSett i:
- Stuttgart, Klinikum Stuttgart
Prøver:- NCT02685605 (Underetterforsker)
Betingelser: -
Marc Piroth, MDSett i:
- Wuppertal, Helios University Hospital Wuppertal
Prøver:- NCT02685605 (Hovedetterforsker)
Betingelser: -
Marianne Schmucker, Dr. med.Sett i:
- Baden-Wuerttemberg, Freiburg i. Br., Department of Radiotherapy, University Hospital Freiburg
Prøver:- NCT01252459 (Underetterforsker)
Betingelser: -
Marion Rapp, PD MDSett i:
- Northrhine Westphalia, Düsseldorf, Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
Prøver:- NCT03395587 (Underetterforsker)
Betingelser: -
Martin Wettig, Dr. med.Sett i:
- Northrhine Westphalia, Duisburg, Klinik für Neurochirurgie, Sana Kliniken Duisburg
Prøver:- NCT03395587 (Hovedetterforsker)
Betingelser: -
Maximilian Niyazi, MD, MScSett i:
- Bavaria, Munich, University of Munich, Dep. of Radiation Oncology
Prøver:- NCT01579253 (Hovedetterforsker)
- NCT05114213 (Hovedetterforsker)
-
Michael Ehmann, MDSett i:
- Mannheim, University Hospital Mannheim
Prøver:- NCT02685605 (Hovedetterforsker)
Betingelser: -
Michael Ronellenfitsch, MD, PhDSett i:
- Frankfurt, Dr. Senckenbergisches Institut für Neuroonkologie
Prøver:- NCT03970447 (Hovedetterforsker)
Betingelser: -
Michael Sabel, Prof. MDSett i:
- Northrhine Westphalia, Düsseldorf, Neurochirurgische Klinik, Universitätsklinikum Düsseldorf
Prøver:- NCT03395587 (Hovedetterforsker)
Betingelser: -
Michael Stoffel, Prof. MDSett i:
- Krefeld, Helios Klinikum Krefeld, Klinik für Neurochirurgie
Prøver:- NCT03395587 (Hovedetterforsker)
Betingelser: -
Muterem Erinola, Prof. Dr.Sett i:
- NRW, Lünen, St. Marien Hospital Lünen, Klinik für Neurochirurgie
Prøver:- NCT03395587 (Underetterforsker)
Betingelser: -
Nicole Wiedenmann, Dr. med.Sett i:
- Baden-Wuerttemberg, Freiburg i. Br., Department of Radiotherapy, University Hospital Freiburg
Prøver:- NCT01252459 (Underetterforsker)
Betingelser: -
Nima Etminan, MDSett i:
- Mannheim, University Hospital Mannheim
Prøver:- NCT02685605 (Underetterforsker)
Betingelser: -
Nora Bünger, Dr. med.Sett i:
- Northrhine Westphalia, Münster, Klinik für Allgemeine Neurologie, Universitätsklinikum Münster
Prøver:- NCT03395587 (Underetterforsker)
Betingelser: -
Norbert Galldiks, Prof.Sett i:
- Cologne, Uniklinik Koeln - Zentrum fuer Neurologie und Psychiatrie
Prøver:- NCT03970447 (Hovedetterforsker)
Betingelser: -
Oliver Ganslandt, MDSett i:
- Stuttgart, Klinikum Stuttgart
Prøver:- NCT02685605 (Hovedetterforsker)
Betingelser:
Kliniske studier på Glioblastom
-
Celldex TherapeuticsFullførtGlioblastom | Gliosarkom | Tilbakevendende glioblastom | Småcellet glioblastom | Kjempecelleglioblastom | Glioblastom med oligodendroglial komponent | Tilbakefallende glioblastomForente stater
-
Northwestern UniversityNational Cancer Institute (NCI)RekrutteringGlioblastom | Astrocytom | Tilbakevendende glioblastom | MGMT-Umetylert glioblastom | Glioblastom, IDH-villtypeForente stater
-
Istituto Oncologico Veneto IRCCSBayer S.p.ARekrutteringGlioblastom, IDH-villtype | MGMT-metylert glioblastomItalia
-
Northwestern UniversityNational Cancer Institute (NCI); Moleculin Biotech, Inc.Har ikke rekruttert ennåMGMT-Umetylert glioblastom | Glioblastom, IDH-villtypeForente stater
-
Vastra Gotaland RegionKarolinska Institutet; Oslo University Hospital; Aarhus University Hospital; Sahlgrenska University Hospital, Sweden og andre samarbeidspartnereHar ikke rekruttert ennåGlioblastom, IDH-villtype | MGMT-metylert glioblastom
-
Massachusetts General HospitalHar ikke rekruttert ennåGlioblastom tilbakevendende, EGFR vIII mutant | Nydiagnostisert glioblastom, EGFRvIII-mutant | Tilbakevendende glioblastom, EGFR vIII negativForente stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutteringTilbakevendende glioblastom | Ildfast glioblastomForente stater
-
National Cancer Institute (NCI)SuspendertTilbakevendende glioblastom, IDH-Wildtype | MGMT-metylert glioblastom | Tilbakevendende MGMT-metylert glioblastomForente stater
-
Northwestern UniversityAgenus Inc.; CarTheraRekrutteringGlioblastoma Multiforme | Gliosarkom | Nylig diagnostisert glioblastom | Glioblastom, isositrisk dehydrogenase (IDH)-villtypeForente stater
-
Celldex TherapeuticsFullførtGlioblastom | Gliosarkom | Småcellet glioblastom | Kjempecelleglioblastom | Glioblastom med oligodendroglial komponentForente stater, Canada, Australia, Israel, Taiwan, Storbritannia, Belgia, Frankrike, Spania, Tyskland, Østerrike, Brasil, Colombia, Tsjekkia, Hellas, Ungarn, India, Italia, Mexico, Nederland, New Zealand, Peru, Sveits, Thailand